Herpes stromal keratitis (HSK) is a potentially blinding disease caused by herpes simplex virus corneal infection. Most cases of HSK are due to reactivation of the virus from latency leading to ...

According to Robert Latkany, MD, understanding the causes and recognizing these diagnostic features are essential for effective treatment.

Claris Biotherapeutics is developing ocular biologic solution for the treatment of neurotrophic keratitis. The company is headquartered in Jersey City, New Jersey, the US. For a complete picture of ...

The European Commission has approved SIFI's Akantior as the first therapy anywhere in the world for acanthamoeba keratitis (AK), an ultra-rare parasitic infection that can lead to blindness.

KNOXVILLE, Tenn., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced a $3 million seed financing round for VisiRose, Inc.

Claris Biotherapeutics is developing ocular biologic solution for the treatment of neurotrophic keratitis. The company is headquartered in Jersey City, New Jersey, the US. For a complete picture of ...

CATANIA, Italy, Dec. 16, 2024 /PRNewswire/ -- SIFI, a leading international ophthalmic company, announced the accomplishment of a key milestone in the pursuit of regulatory approvals in the United ...